Arclio develops AI tools that help clinical-stage biotech companies analyze trial data and prepare FDA submissions faster. Our platform automates survival analysis, safety profiling, and regulatory-ready reporting, capabilities typically locked inside large CROs, making them accessible to lean R&D teams. Currently active with Cellectar Biosciences (Phase II/III oncology).